Page last updated: 2024-08-25

uk 68798 and Cardiovascular Stroke

uk 68798 has been researched along with Cardiovascular Stroke in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (42.11)18.2507
2000's10 (52.63)29.6817
2010's1 (5.26)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE1
Abildstrøm, SZ; Køber, L; Pedersen, OD; Schmiegelow, MD; Seibæk, M; Torp-Pedersen, C1
Burchardt, H; Hintze, U; Møller, M; Vach, W; Videbaek, J1
Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL1
Brendorp, B; Elming, H; Jun, L; Køber, L; Torp-Pedersen, C1
Pratt, CM1
Cvetanovic, I; Ke, X; Lin, C; Ranade, V; Somberg, J1
Bhatia, GS; Lip, GY1
Feldman, S; Glikson, M; Levitan, J; Lewkowicz, M; Olesen, RM; Saermark, K; Thomsen, PE1
Brendorp, B; Burchardt, H; Elming, H; Køber, L; Pedersen, HS; Seibaek, M; Torp-Pedersen, C1
D'Alonzo, AJ; Darbenzio, RB; Dzwonczyk, S; Grover, GJ; Parham, CS1
Chen, J; Eto, K; Hashimoto, K; Ni, C; Xue, Y1
Møller, M1
Bugge, E; Løkebø, JE; Munch-Ellingsen, J; Ytrehus, K1
Agner, E; Bloch Thomsen, PE; Camm, AJ; Carlsen, J; Egstrup, K; Køber, L; Marchant, B; Møller, M; Sandøe, E; Torp-Pedersen, C; Videbaek, J1
Bagger, H; Keller, N; Køber, L; Marchant, B; Pedersen, OD; Torp-Pedersen, C1
Arrowsmith, JE; Blackburn, KJ; Burges, RA; Cross, PE; Dalrymple, HW; Gwilt, M; Higgins, AJ1
Corr, PB; Zuanetti, G1

Reviews

3 review(s) available for uk 68798 and Cardiovascular Stroke

ArticleYear
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    The American journal of cardiology, 2003, Mar-20, Volume: 91, Issue:6A

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States

2003
Pure class III agents for prevention of sudden cardiac death.
    Journal of cardiovascular electrophysiology, 2003, Volume: 14, Issue:9 Suppl

    Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Comorbidity; Death, Sudden, Cardiac; Europe; Humans; Hydantoins; Imidazoles; Imidazolidines; Middle Aged; Myocardial Infarction; Phenethylamines; Piperazines; Randomized Controlled Trials as Topic; Sotalol; Sulfonamides; Survival Analysis; Treatment Outcome

2003
Atrial fibrillation post-myocardial infarction: frequency, consequences, and management.
    Current heart failure reports, 2004, Volume: 1, Issue:4

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Failure; Humans; Incidence; Myocardial Infarction; Phenethylamines; Potassium Channel Blockers; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides

2004

Trials

6 trial(s) available for uk 68798 and Cardiovascular Stroke

ArticleYear
The prognostic value of QTc interval and QT dispersion following myocardial infarction in patients treated with or without dofetilide.
    Clinical cardiology, 2003, Volume: 26, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Denmark; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Phenethylamines; Prognosis; Proportional Hazards Models; Risk Factors; Sulfonamides; Survival Analysis; Systole; Treatment Outcome; Ventricular Dysfunction, Left

2003
Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.
    The American journal of cardiology, 2007, Sep-01, Volume: 100, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Output, Low; Cause of Death; Double-Blind Method; Electrocardiography; Female; Forecasting; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Placebos; Potassium Channel Blockers; Risk Factors; Sex Factors; Sulfonamides; Time Factors; Torsades de Pointes; Ventricular Dysfunction, Left

2007
DIAMOND antiarrhythmic trials. Danish Investigations of Arrhythmia and Mortality on Dofetilide.
    Lancet (London, England), 1996, Dec-07, Volume: 348, Issue:9041

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Denmark; Heart Failure; Humans; Myocardial Infarction; Patient Selection; Phenethylamines; Risk; Sulfonamides

1996
Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
    Clinical cardiology, 1997, Volume: 20, Issue:8

    Topics: Aged; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Denmark; Double-Blind Method; Female; Heart Failure; Humans; Male; Myocardial Infarction; Patient Selection; Phenethylamines; Potassium Channel Blockers; Research Design; Risk Factors; Sulfonamides; Ventricular Dysfunction, Left

1997
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
    Lancet (London, England), 2000, Dec-16, Volume: 356, Issue:9247

    Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Sulfonamides; Ventricular Dysfunction, Left

2000
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
    Circulation, 2001, Jul-17, Volume: 104, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Denmark; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Phenethylamines; Sulfonamides; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left

2001

Other Studies

10 other study(ies) available for uk 68798 and Cardiovascular Stroke

ArticleYear
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
    Journal of medicinal chemistry, 1993, Oct-29, Volume: 36, Issue:22

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship

1993
Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
    BMC cardiovascular disorders, 2011, May-14, Volume: 11

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Cohort Studies; Denmark; Electrocardiography; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2011
QT interval dynamics predict mortality in high-risk patients after myocardial infarction.
    Scandinavian cardiovascular journal : SCJ, 2002, Volume: 36, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Male; Multivariate Analysis; Myocardial Infarction; Observer Variation; Phenethylamines; Predictive Value of Tests; Prospective Studies; Risk Factors; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left

2002
The influence of extracellular acidosis on the effect of IKr blockers.
    Journal of cardiovascular pharmacology and therapeutics, 2005, Volume: 10, Issue:1

    Topics: Acidosis; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Humans; Hydantoins; Imidazolidines; Myocardial Infarction; Oocytes; Phenethylamines; Piperazines; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Sulfonamides; Trans-Activators; Xenopus laevis

2005
Statistical analysis of the DIAMOND MI study by the multipole method.
    Physiological measurement, 2005, Volume: 26, Issue:5

    Topics: Double-Blind Method; Electrocardiography; Heart Rate; Humans; Myocardial Infarction; Phenethylamines; Randomized Controlled Trials as Topic; Statistics as Topic; Sulfonamides

2005
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide.
    The American journal of physiology, 1996, Volume: 271, Issue:3 Pt 2

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenethylamines; Pilot Projects; Potassium; Reaction Time; Sulfonamides

1996
Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Digitalis; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Epinephrine; Female; Male; Myocardial Infarction; Myocardial Reperfusion; Phenethylamines; Plants, Medicinal; Plants, Toxic; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation

1996
Potassium channel blocker dofetilide does not abolish ischaemic preconditioning.
    Scandinavian journal of clinical and laboratory investigation, 1997, Volume: 57, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Electrophysiology; Hemodynamics; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Phenethylamines; Potassium Channel Blockers; Rabbits; Risk Factors; Sulfonamides

1997
UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:1

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dogs; Evaluation Studies as Topic; Guinea Pigs; Heart; Heart Ventricles; Male; Membrane Potentials; Myocardial Infarction; Myocardium; Papillary Muscles; Phenethylamines; Potassium Channels; Purkinje Fibers; Sulfonamides; Ventricular Function

1991
Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dogs; Electric Stimulation; Electrocardiography; Heart; Heart Conduction System; Heart Ventricles; Myocardial Infarction; Phenethylamines; Sulfonamides; Tachycardia; Ventricular Fibrillation

1991